Pro- and Anti-inflammatory Cytokines in PCOS
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorJagiellonian University
About this trial
The study will involve measurements and comparisons of the concentrations of pro-inflammatory cytokines: IL-6, TNF-α, IL-18, as well as anti-inflammatory cytokine IL-4 in women with polycystic ovary syndrome (PCOS) and insulin resistance, women with polycystic ovary syndrome without carbohydrate metabolism disorders, and women without PCOS (control group).
Eligibility criteria
Qualifiers
women aged 18-45 years
Disqualifiers
previous removal of at least one ovary
treated diabetes of any type
diagnosed and treated metabolic diseases
diagnosed and treated autoimmune diseases
Trial design
Treatments tested in this trial
- Measurement of interleukin-6 (il-6) concentration in blood serum
- Measurement of fasting tumor necrosis factor α (TNF-α) concentration
- Measurement of interleukin-18 (il-18) concentration
- Measurement of interleukin-4 (il-4) concentration
Treatment groups
100 Participants
are divided into 3 treatment groupsLocations
1Jagiellonian University Krakow Poland
Sponsors and collaborators
Jagiellonian University
Lead sponsor
Source ClinicalTrials.gov